Breaking News

Yesterday Show Full Stories X To view all stories in expanded form, please subscribe. Get Free Trial Send Info
Conference/Events	Cantor Fitzgerald biotech to hold analyst/industry dinner meeting » 16:34 06/02/23 06/02 16:34 06/02/23 16:34 ASND Ascendis Pharma $91.27 / +3.36 (+3.82%) , ZYME Zymeworks $8.67 / +0.18 (+2.12%) , BCYC Bicycle Therapeutics $25.23 / +1.105 (+4.58%) , IOVA Iovance Biotherapeutics $8.80 / +0.07 (+0.80%) , KURA Kura Oncology $13.19 / -0.3 (-2.22%) , PFE Pfizer $38.36 / +0.325 (+0.85%) , ARVN Arvinas $23.24 / +1.505 (+6.92%) , RHHBY Roche $40.39 / +0.42 (+1.05%) , SNY Sanofi $51.01 / +0.59 (+1.17%) , AZN AstraZeneca $72.57 / -0.27 (-0.37%) , LLY Eli Lilly $441.99 / +5.515 (+1.26%) , ALXO ALX Oncology $8.34 / +0.965 (+13.09%) , PRTG Portage Biotech $3.64 / -0.07 (-1.89%) Biotech Analyst Watsek… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 5th, 16:34 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options ZYME SNY RHHBY PFE LLY KURA IOVA BCYC AZN ASND ARVN ALXO ZYME Zymeworks $8.67 / +0.18 (+2.12%) 05/18/23 Zymeworks president, COO Neil Klompas departs 03/30/23 Zymeworks discloses $1.6M purchase of common stock by Ecor1 Capital 01/23/23 Zymeworks shareholder EcoR1 Capital buys $3.0M in company shares 01/19/23 Jazz Pharmaceuticals, Zymeworks report 84% survival for zanidatamab in mGEA SNY Sanofi $51.01 / +0.59 (+1.17%) 05/31/23 Sanofi announces new data on frexalimab, to present at 2023 CMSC 05/21/23 Regeneron, Sanofi present Dupixent late-breaking Phase 3 COPD results 05/18/23 Sanofi 'pleased' with Supreme Court's ruling on Amgen's asserted patent claims 05/18/23 Supreme Court upholds Sanofi PCSK9 drug patent victory over Amgen RHHBY Roche $40.39 / +0.42 (+1.05%) 05/17/23 Genentech announces fenebrutinib study met primary, secondary endpoint 05/09/23 Genentech announces FDA acceptance of Vabysmo sBLA 04/26/23 Roche reports CHMP recommends EU approval of fixed-duration Columvi 04/26/23 Zentalis enters agreements with Foundation Medicine, Roche PFE Pfizer $38.36 / +0.325 (+0.85%) 06/01/23 Pfizer announces results from Phase 3 program of REVISIT, ASSEMBLE studies 05/31/23 Pfizer says FDA approves RSV prevention vaccine 05/30/23 Seagen shareholders approve acquisition by Pfizer 05/30/23 Pfizer's marstacimab shows significant efficacy in Phase 3 hemophilia trial LLY Eli Lilly $441.99 / +5.515 (+1.26%) 05/26/23 Attorneys announce over $500M pact with Eli Lilly to settle class-action suit 05/23/23 Moderna, BioNTech other Covid vaccine makers jump amid China Covid scare 05/18/23 Eli Lilly announces detailed results from peresolimab study published in NEJM 05/03/23 Biogen slips after competitor Eli Lilly's Alzheimer's trial hits target KURA Kura Oncology $13.19 / -0.3 (-2.22%) 04/17/23 Kura reports preclinical data on use of farnesyl transferase inhibitors 02/09/23 Kura Oncology announces first patients dosed in Phase 2 trial of ziftomenib 01/24/23 Kura Oncology jumps 6% to $14.85 as FDA clears its IND application for KO-2806 01/24/23 Kura Oncology announces FDA clearance of IND application for KO-2806 IOVA Iovance Biotherapeutics $8.80 / +0.07 (+0.80%) 05/26/23 Iovance Biotherapeutics announces FDA acceptance of BLA of Lifileucel 03/24/23 Iovance Biotherapeutics completes BLA submission for lifileucel 03/10/23 Iovance says it does not hold deposits, securities at Silicon Valley Bank 01/23/23 Clinigen divests Proleukin to Iovance Biotherapeutics for GBP 166.7M BCYC Bicycle Therapeutics $25.23 / +1.105 (+4.58%) 05/11/23 Bicycle Therapeutics and Orano Med report radio-conjugate data results 05/10/23 Bicycle Therapeutics jumps 8% after Bayer oncology pact, milestone payment 05/10/23 Bicycle to receive $45M upfront, plus future milestones in Bayer oncology pact 04/03/23 Bicycle Therapeutics names Santiago Arroyo, M.D Chief Development Officer AZN AstraZeneca $72.57 / -0.27 (-0.37%) 06/02/23 AstraZeneca's IMFINZI plus chemo improved pathologic response in Phase III trial 06/02/23 AstraZeneca says Imfinzi plus chemotherapy showed clinical benefit in trial 06/01/23 AstraZeneca, Merck announce LYNPARZA + abiraterone approved for BRCAm cancer 06/01/23 Merck and AstraZeneca's Lynparza prostate cancer combination approved by FDA ASND Ascendis Pharma $91.27 / +3.36 (+3.82%) 05/31/23 Ascendis Pharma announces oncology program update 05/01/23 Ascendis Pharma receives FDA CRL for TransCon PTH in hypoparathyroidism 04/03/23 Ascendis Pharma falls 38% after disclosing FDA notice of deficiencies in NDA 04/03/23 Ascendis' Phase 1/2 initial trial results of TransCon accepted for ASCO 2023 ARVN Arvinas $23.24 / +1.505 (+6.92%) 05/05/23 Arvinas expects cash to fund requirements into 2026 04/03/23 Arvinas appoints Page as SVP, Global Head of Oncology Strategy, Program Leader 02/23/23 Arvinas expects cash to fund requirements into 2026 12/16/22 Arvinas appoints Everett Cunningham to board of directors ALXO ALX Oncology $8.34 / +0.965 (+13.09%) 05/11/23 ALX Oncology expects cash to fund operations through mid-2025 05/09/23 ALX Oncology announces first patient dosed in Phase 2 trial of evorpacept 04/25/23 ALX Oncology enters clinical trial collaboration with Sanofi 03/13/23 ALX Oncology, Quantum Leap dose first patient in I-SPY-P1 trial ASND ZYME BCYC IOVA KURA PFE ARVN RHHBY SNY AZN LLY ALXO PRTG ASND Ascendis Pharma $91.27 / +3.36 (+3.82%) 06/02/23 Wedbush Ascendis Pharma price target raised to $187 from $186 at Wedbush 05/08/23 Wedbush Ascendis Pharma added to Best Ideas List at Wedbush 04/28/23 Cantor Fitzgerald Ascendis Pharma price target raised to $152 from $142 at Cantor Fitzgerald 04/12/23 Morgan Stanley Ascendis Pharma price target lowered to $107 from $108 at Morgan Stanley ZYME Zymeworks $8.67 / +0.18 (+2.12%) 05/18/23 Citi Zymeworks price target raised to $18 from $17 at Citi 05/09/23 Stifel Zymeworks price target raised to $19 from $18 at Stifel 03/20/23 Wells Fargo Zymeworks coverage transferred at Wells Fargo with Overweight rating 03/10/23 Citi Zymeworks price target lowered to $17 from $21 at Citi BCYC Bicycle Therapeutics $25.23 / +1.105 (+4.58%) 01/04/23 EF Hutton Bicycle Therapeutics initiated with a Buy at EF Hutton 01/02/23 Barclays Barclays views GSK acquisition interest as positive for oncology stocks 11/10/22 Piper Sandler Bicycle Therapeutics price target raised to $48 from $37 at Piper Sandler 11/09/22 JMP Securities Bicycle Therapeutics price target lowered to $46 from $70 at JMP Securities IOVA Iovance Biotherapeutics $8.80 / +0.07 (+0.80%) 05/30/23 Wells Fargo Iovance upgraded to Overweight at Wells Fargo after lifileucel BLA accepted 05/30/23 Wells Fargo Iovance Biotherapeutics upgraded to Overweight from Equal Weight at Wells Fargo 05/30/23 Stifel Iovance Biotherapeutics price target raised to $24 from $21 at Stifel 05/29/23 Barclays Iovance news 'important clearing event' for shares, says Barclays KURA Kura Oncology $13.19 / -0.3 (-2.22%) 05/31/23 Barclays Barclays reveals two small cap ideas into ASCO conference 05/16/23 BTIG Kura Oncology initiated with a Buy at BTIG 05/11/23 Stifel Kura Oncology price target lowered to $24 from $25 at Stifel 04/17/23 H.C. Wainwright Kura Oncology data support KO-2806 combination studies, says H.C. Wainwright PFE Pfizer $38.36 / +0.325 (+0.85%) 05/23/23 Jefferies Jefferies says Pfizer oral GLP-1 safety and tolerability 'important to note' 05/22/23 Pfizer weight loss drug may be as effective, quicker than Ozempic, CNBC says 05/19/23 BofA AdComm support for Pfizer's infant RSV vaccine 'not surprising,' says BofA 05/16/23 Stifel Seagen likely to stay 'distanced' from deal price after FTC action, says Stifel ARVN Arvinas $23.24 / +1.505 (+6.92%) 05/08/23 Stifel Arvinas price target lowered to $72 from $75 at Stifel 03/18/23 Citi Arvinas price target raised to $77 from $72 at Citi 02/23/23 Capital One Arvinas remains one of the best biotechs to own, says Capital One 01/17/23 Truist Arvinas price target lowered to $65 from $100 at Truist RHHBY Roche $40.39 / +0.42 (+1.05%) 05/19/23 Piper Sandler Regeneron Q1 Eylea miss 'not about share, says Piper Sandler 05/08/23 Guggenheim Regeneron price target lowered to $935 from $960 at Guggenheim 04/10/23 BofA BofA questions relevance of Briumvi tracking to Q1 beat, says TG move 'overdone' 03/27/23 Barclays Roche downgraded to Equal Weight from Overweight at Barclays SNY Sanofi $51.01 / +0.59 (+1.17%) 05/04/23 Raymond James Kymera Therapeutics upgraded to Outperform from Market Perform at Raymond James 04/28/23 Deutsche Bank Sanofi downgraded to Sell from Hold at Deutsche Bank 04/28/23 Deutsche Bank Sanofi downgraded to Sell from Hold at Deutsche Bank AZN AstraZeneca $72.57 / -0.27 (-0.37%) 05/26/23 Argus AstraZeneca price target lowered to $80 from $85 at Argus 05/09/23 Berenberg AstraZeneca price target raised to 135 GBp from 124 GBp at Berenberg 04/28/23 JPMorgan AstraZeneca price target raised to 14,000 GBp from 13,500 GBp at JPMorgan 04/13/23 Argus AstraZeneca price target raised to $85 from $75 at Argus LLY Eli Lilly $441.99 / +5.515 (+1.26%) 05/26/23 Wells Fargo Eli Lilly price target raised to $500 from $440 at Wells Fargo 05/24/23 BofA Eli Lilly price target raised to $500 from $450 at BofA 05/23/23 TD Cowen Eli Lilly price target raised to $500 from $430 at TD Cowen 05/19/23 JPMorgan JPMorgan places 'Negative Catalyst Watch' on Novartis into data ALXO ALX Oncology $8.34 / +0.965 (+13.09%) 03/14/23 UBS ALX Oncology price target lowered to $29 from $31 at UBS 03/10/23 H.C. Wainwright ALX Oncology price target lowered to $30 from $65 at H.C. Wainwright 11/09/22 Cantor Fitzgerald ALX Oncology price target lowered to $22 from $32 at Cantor Fitzgerald 11/09/22 H.C. Wainwright ALX Oncology price target lowered to $65 from $80 at H.C. Wainwright PRTG Portage Biotech $3.64 / -0.07 (-1.89%) 12/01/22 H.C. Wainwright Portage Biotech price target lowered to $21 from $22 at H.C. Wainwright 11/30/22 Cantor Fitzgerald Portage Biotech price target lowered to $18 from $26 at Cantor Fitzgerald 11/30/22 Oppenheimer Portage Biotech price target lowered to $18 from $26 at Oppenheimer 09/20/22 H.C. Wainwright Portage Biotech price target lowered to $22 from $32 at H.C. Wainwright ZYME SNY RHHBY PRTG PFE LLY KURA IOVA BCYC AZN ARVN ALXO ZYME Zymeworks $8.67 / +0.18 (+2.12%) 05/08/23 Zymeworks reports Q1 adjusted EPS (34c), consensus (54c) 03/07/23 Zymeworks reports Q4 EPS $4.65, consensus $4.84 SNY Sanofi $51.01 / +0.59 (+1.17%) 04/27/23 Sanofi confirms FY23 business EPS view of up low single digits at CER 04/27/23 Sanofi reports Q1 business EPS EUR 2.16, up 11.9% at CER 03/30/23 IGM Biosciences Sanofi sees FY23 revenue $3M, consensus $5.5M 02/03/23 Sanofi sees 2023 business EPS up at low single digit rate at CER RHHBY Roche $40.39 / +0.42 (+1.05%) 04/26/23 Roche confirms outlook for FY23 04/26/23 Roche reports Q1 group sales CHF 15.32B vs. CHF 16.45B last year 02/02/23 Roche reports FY22 core EPS CHF20.30 vs. CHF19.81 last year PRTG Portage Biotech $3.64 / -0.07 (-1.89%) 03/01/23 Portage Biotech reports Q4 EPS (44c), consensus (23c) PFE Pfizer $38.36 / +0.325 (+0.85%) 05/02/23 Pfizer backs FY23 adjusted EPS view $3.25-$3.45, consensus $3.36 05/02/23 Pfizer reports Q1 adjusted EPS $1.23, consensus 98c 03/15/23 Royalty Pharma raises FY23 adjusted cash receipt guidance to $2.85B-$2.95B 01/31/23 Pfizer sees FY23 adjusted EPS $3.25-$3.45, consensus $4.44 LLY Eli Lilly $441.99 / +5.515 (+1.26%) 04/27/23 Eli Lilly raises FY23 adjusted EPS view to $8.65-$8.85 from $8.35-$8.55 04/27/23 Eli Lilly reports Q1 EPS $1.62, consensus $1.73 04/26/23 Notable companies reporting before tomorrow's open KURA Kura Oncology $13.19 / -0.3 (-2.22%) 02/23/23 Kura Oncology reports Q4 EPS (49c), consensus (57c) IOVA Iovance Biotherapeutics $8.80 / +0.07 (+0.80%) 05/09/23 Iovance Biotherapeutics reports Q1 EPS (50c), consensus (74c) 02/28/23 Iovance Biotherapeutics reports Q4 EPS (64c), consensus (64c) BCYC Bicycle Therapeutics $25.23 / +1.105 (+4.58%) 05/04/23 Bicycle Therapeutics reports Q1 EPS ($1.30), consensus ($1.07) 02/28/23 Bicycle Therapeutics reports Q4 EPS ($1.01), consensus ($1.06) AZN AstraZeneca $72.57 / -0.27 (-0.37%) 04/27/23 AstraZeneca sees FY23 core EPS up high single to low double-digit percentage 04/27/23 AstraZeneca reports Q1 core EPS $1.92, consensus $1.07 02/09/23 AstraZeneca sees FY23 core EPS up high single to low double-digit percentage 02/09/23 AstraZeneca reports Q4 core EPS $1.38, consensus $1.35 ARVN Arvinas $23.24 / +1.505 (+6.92%) 05/05/23 Arvinas reports Q1 EPS ($1.54), consensus ($1.51) 02/23/23 Arvinas reports Q4 EPS ($1.56), consensus ($1.22) ALXO ALX Oncology $8.34 / +0.965 (+13.09%) 05/11/23 ALX Oncology reports Q1 EPS (74c), consensus (80c) SNY RHHBY PFE LLY AZN SNY Sanofi $51.01 / +0.59 (+1.17%) 04/12/23 Sanders to call CEOs of largest insulin makers to testify, STAT says 01/30/23 Sanofi plans to lay off staff at vaccine factories in India, Reuters says 01/23/23 CytoReason to license IBD disease model to Sanofi 01/13/23 Johnson & Johnson cuts production of Covid-19 vaccine, WSJ reports RHHBY Roche $40.39 / +0.42 (+1.05%) 05/10/23 BioNTech data was reported in June 2022, Reuters reports 01/11/23 Roche looks internally for pharmaceutical unit chief, Bloomberg reports PFE Pfizer $38.36 / +0.325 (+0.85%) 05/26/23 Health authorities to target next COVID shot to new strain, WSJ says 05/23/23 China's new Covid surge could result in 65M infections a week, Bloomberg says 05/14/23 Pfizer Pfizer, Stryker have strong growth prospects, Barron's says 05/10/23 BioNTech pancreatic cancer vaccine 'shows promise' in small trial, NYT says LLY Eli Lilly $441.99 / +5.515 (+1.26%) 04/24/23 Novo Nordisk, Lilly lobby for Medicare coverage of weight-loss drug, WSJ report 04/11/23 Drugmakers call for abortion pill ruling reversal, Reuters reports 04/10/23 Weight-loss business upended by popularity of ozempic, other drugs, WSJ reports AZN AstraZeneca $72.57 / -0.27 (-0.37%) 05/19/23 Astra China head says company seeks to 'love the Communist Party,' Reuters says 05/04/23 AstraZeneca chair says increasing CEO's pay wards of rivals, FT reports 04/06/23 GSK unit ordered to pay AstraZeneca royalties on Zejula sales, Reuters says ZYME SNY RHHBY PFE LLY KURA IOVA AZN ASND ZYME Zymeworks $8.67 / +0.18 (+2.12%) 03/08/23 Fly Intel: Pre-market Movers 01/12/23 Fly Intel: After-Hours Movers 12/19/22 What You Missed On Wall Street On Monday 12/19/22 What You Missed On Wall Street This Morning SNY Sanofi $51.01 / +0.59 (+1.17%) 05/10/23 What Wall Street is saying about Disney ahead of earnings 03/23/23 What You Missed On Wall Street On Thursday 03/23/23 What You Missed On Wall Street This Morning 03/14/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations RHHBY Roche $40.39 / +0.42 (+1.05%) 01/23/23 Biotech Alert: Searches spiking for these stocks today 01/12/23 Meet ZyVersa: Fly exclusive interview with CEO Stephen Glover PFE Pfizer $38.36 / +0.325 (+0.85%) 05/16/23 What You Missed On Wall Street On Tuesday 05/02/23 What You Missed On Wall Street On Tuesday 05/02/23 What You Missed On Wall Street This Morning 03/21/23 What You Missed On Wall Street On Tuesday LLY Eli Lilly $441.99 / +5.515 (+1.26%) 05/03/23 What You Missed On Wall Street On Wednesday 05/03/23 What You Missed On Wall Street This Morning 05/03/23 Fly Intel: Pre-market Movers 04/27/23 What You Missed On Wall Street On Thursday KURA Kura Oncology $13.19 / -0.3 (-2.22%) 05/17/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/21/23 Biotech Alert: Searches spiking for these stocks today IOVA Iovance Biotherapeutics $8.80 / +0.07 (+0.80%) 06/02/23 Biotech Alert: Searches spiking for these stocks today 06/01/23 Biotech Alert: Searches spiking for these stocks today 05/30/23 What You Missed On Wall Street On Tuesday 05/30/23 What You Missed On Wall Street This Morning AZN AstraZeneca $72.57 / -0.27 (-0.37%) 04/11/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/05/23 What You Missed On Wall Street On Wednesday 04/05/23 What You Missed On Wall Street This Morning 02/09/23 What You Missed On Wall Street This Morning ASND Ascendis Pharma $91.27 / +3.36 (+3.82%) 05/04/23 Biotech Alert: Searches spiking for these stocks today 05/03/23 Biotech Alert: Searches spiking for these stocks today 04/06/23 Biotech Alert: Searches spiking for these stocks today 04/05/23 Biotech Alert: Searches spiking for these stocks today 06/02/23 Biotechnology--Pre-ASCO Reception 06/12/23 Biotech/Biopharma 06/28/23 Biotech/Biopharma 06/28/23 Biotech/Biopharma 08/02/23 Biotech/Biopharma 06/02/23 2023 ASCO Annual Meeting 06/02/23 Truist Hosted Company Events at 2023 ASCO Annual Meeting 08/08/23 Eli Lilly - LLY 07/01/23 PDUFA Date for Glofitamab 11/25/23 PDUFA Date for Lifileucel 12/22/23 PDUFA Date for Eplontersen 06/06/23 Iovance Biotherapeutics, Inc. 06/12/23 Kura Oncology 06/15/23 Arvinas, Inc. 06/16/23 ALX Oncology Holdings Inc. 06/27/23 Bicycle Therapeutics PFE LLY AZN PFE Pfizer $38.36 / +0.325 (+0.85%) 05/24/23 Notable open interest changes for May 24th 05/23/23 Unusually active option classes on open May 23rd 05/23/23 Notable open interest changes for May 23rd 05/23/23 Unusual call flow in option market yesterday LLY Eli Lilly $441.99 / +5.515 (+1.26%) 03/13/23 Early notable gainers among liquid option names on March 13th 03/10/23 Early notable gainers among liquid option names on March 10th AZN AstraZeneca $72.57 / -0.27 (-0.37%) 05/26/23 Unusually active option classes on open May 26th 05/18/23 Unusually active option classes on open May 18th 05/09/23 AstraZeneca put volume heavy and directionally bearish 04/27/23 Unusually active option classes on open April 27th
Conference/Events	Kura Oncology to host investor day » 16:27 06/02/23 06/02 16:27 06/02/23 16:27 KURA Kura Oncology $13.19 / -0.3 (-2.22%) Investor Day to be held… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 5th, 16:27 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events KURA Kura Oncology $13.19 / -0.3 (-2.22%) 04/17/23 Kura reports preclinical data on use of farnesyl transferase inhibitors 02/09/23 Kura Oncology announces first patients dosed in Phase 2 trial of ziftomenib 01/24/23 Kura Oncology jumps 6% to $14.85 as FDA clears its IND application for KO-2806 01/24/23 Kura Oncology announces FDA clearance of IND application for KO-2806 KURA Kura Oncology $13.19 / -0.3 (-2.22%) 05/31/23 Barclays Barclays reveals two small cap ideas into ASCO conference 05/16/23 BTIG Kura Oncology initiated with a Buy at BTIG 05/11/23 Stifel Kura Oncology price target lowered to $24 from $25 at Stifel 04/17/23 H.C. Wainwright Kura Oncology data support KO-2806 combination studies, says H.C. Wainwright KURA Kura Oncology $13.19 / -0.3 (-2.22%) 02/23/23 Kura Oncology reports Q4 EPS (49c), consensus (57c) KURA Kura Oncology $13.19 / -0.3 (-2.22%) 05/17/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/21/23 Biotech Alert: Searches spiking for these stocks today 06/12/23 Biotech/Biopharma
Hot Stocks	Neurocrine presents data from long term use of INGREZZA » 08:32 06/02/23 06/02 08:32 06/02/23 08:32 NBIX Neurocrine $91.11 / +1.59 (+1.78%) Neurocrine Biosciences… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 5th, 08:32 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events NBIX Neurocrine $91.11 / +1.59 (+1.78%) 05/19/23 Neurocrine: Results from Phase 3 KINECT-HD study published in The Lancet 05/15/23 Neurocrine presents results of Ingrezza capsules in dyskinesia and schizophrenia 05/12/23 Neurocrine to present new analysis of Phase 2 data of crinecerfont in adults 05/03/23 Neurocrine chief HR officer Cooke sells 11,397 common shares NBIX Neurocrine $91.11 / +1.59 (+1.78%) 05/04/23 Canaccord Neurocrine price target lowered to $130 from $132 at Canaccord 05/04/23 Mizuho Neurocrine price target lowered to $111 from $116 at Mizuho 05/04/23 Guggenheim Guggenheim upgrades Neurocrine to Buy on Ingrezza strength, pipeline potential 05/04/23 Citi Neurocrine price target lowered to $122 from $127 at Citi NBIX Neurocrine $91.11 / +1.59 (+1.78%) 05/03/23 Neurocrine reports Q1 adjusted EPS (51c), consensus 13c 02/06/23 Neurocrine reports Q4 non-GAAP EPS $1.24, consensus $1.14 NBIX Neurocrine $91.11 / +1.59 (+1.78%) 05/04/23 What You Missed On Wall Street On Thursday 05/04/23 What You Missed On Wall Street This Morning 05/04/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/03/23 What You Missed On Wall Street On Friday 08/20/23 PDUFA Date for Valbenazine

Thursday
Recommendations	Travere Therapeutics price target raised to $35 from $22 at H.C. Wainwright » 11:15 06/01/23 06/01 11:15 06/01/23 11:15 TVTX Travere Therapeutics $17.88 / +0.01 (+0.06%) H.C. Wainwright raised… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly TVTX Travere Therapeutics $17.88 / +0.01 (+0.06%) 05/31/23 Travere Therapeutics announces results from cohort 6 of Phase 1/2 COMPOSE study 05/01/23 Travere Therapeutics down 24% at $17.25 after announcing sparsentan study data 05/01/23 Travere Therapeutics' sparsentan study did not achieve primary efficacy 04/02/23 Travere Therapeutics announces interim analysis from Phase 3 PROTECT study TVTX Travere Therapeutics $17.88 / +0.01 (+0.06%) 05/22/23 TD Cowen Travere initiated with Outperform, $30 target at TD Cowen 05/22/23 TD Cowen Travere Therapeutics initiated with an Outperform at TD Cowen 05/09/23 Canaccord Travere Therapeutics price target lowered to $37 from $42 at Canaccord TVTX Travere Therapeutics $17.88 / +0.01 (+0.06%) 05/04/23 Travere Therapeutics reports Q2 adjusted EPS (82c), consensus ($1.17) 02/23/23 Travere Therapeutics reports Q4 EPS ($1.03), consensus ($1.07) 01/09/23 Travere Therapeutics sees Q4 net product sales $52M, consensus $57.15 01 Mar TVTX Travere Therapeutics $17.88 / +0.01 (+0.06%) 05/02/23 What You Missed On Wall Street On Tuesday 05/02/23 What You Missed On Wall Street This Morning 05/01/23 Fly Intel: After-Hours Movers 02/21/23 What You Missed On Wall Street On Tuesday

Wednesday
Hot Stocks	Travere Therapeutics announces results from cohort 6 of Phase 1/2 COMPOSE study » 07:11 05/31/23 05/31 07:11 05/31/23 07:11 TVTX Travere Therapeutics $16.42 / -0.01 (-0.06%) Travere Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 03:50:58 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly TVTX Travere Therapeutics $16.42 / -0.01 (-0.06%) 05/01/23 Travere Therapeutics down 24% at $17.25 after announcing sparsentan study data 05/01/23 Travere Therapeutics' sparsentan study did not achieve primary efficacy 04/02/23 Travere Therapeutics announces interim analysis from Phase 3 PROTECT study 02/17/23 Ligand's partner Travere Therapeutics gets FDA accelerated approval of Filspari TVTX Travere Therapeutics $16.42 / -0.01 (-0.06%) 05/22/23 TD Cowen Travere initiated with Outperform, $30 target at TD Cowen 05/22/23 TD Cowen Travere Therapeutics initiated with an Outperform at TD Cowen 05/09/23 Canaccord Travere Therapeutics price target lowered to $37 from $42 at Canaccord TVTX Travere Therapeutics $16.42 / -0.01 (-0.06%) 05/04/23 Travere Therapeutics reports Q2 adjusted EPS (82c), consensus ($1.17) 02/23/23 Travere Therapeutics reports Q4 EPS ($1.03), consensus ($1.07) 01/09/23 Travere Therapeutics sees Q4 net product sales $52M, consensus $57.15 01 Mar TVTX Travere Therapeutics $16.42 / -0.01 (-0.06%) 05/02/23 What You Missed On Wall Street On Tuesday 05/02/23 What You Missed On Wall Street This Morning 05/01/23 Fly Intel: After-Hours Movers 02/21/23 What You Missed On Wall Street On Tuesday
Conference/Events	Halozyme management to meet with Evercore ISI » 06:23 05/31/23 05/31 06:23 05/31/23 06:23 HALO Halozyme $32.86 / -0.36 (-1.08%) Meeting to be held in New… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 04:03:54 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events HALO Halozyme $32.86 / -0.36 (-1.08%) 03/15/23 Halozyme provides update on EPO decision regarding Darzalex 03/01/23 Halozyme director Henderson sells 20,000 common shares 01/10/23 Halozyme falls 7% to $52.00 after below-consensus FY23 guidance 01/10/23 Halozyme announces anticipated key events in 2023 HALO Halozyme $32.86 / -0.36 (-1.08%) 05/10/23 Piper Sandler Halozyme upgraded to Overweight from Neutral at Piper Sandler 03/27/23 Berenberg Halozyme resumed with a Buy at Berenberg 03/16/23 SVB Securities SVB Securities downgrades Halozyme to Market Perform given growth uncertainty 03/16/23 SVB Securities Halozyme downgraded to Market Perform from Outperform at SVB Securities HALO Halozyme $32.86 / -0.36 (-1.08%) 05/09/23 Halozyme sees FY23 non-GAAP EPS $2.50-$2.65, consensus $2.57 05/09/23 Halozyme reports Q1 non-GAAP EPS 47c, consensus 48c 03/15/23 Halozyme reaffirms FY23 revenue view $815M-$845M, consensus $829.01M 02/21/23 Halozyme sees FY23 adjusted EPS $2.50-$2.65, consensus $2.78 HALO Halozyme $32.86 / -0.36 (-1.08%) 03/27/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/16/23 What You Missed On Wall Street On Thursday 03/16/23 What You Missed On Wall Street This Morning 03/16/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/31/23 Halozyme
Recommendations	Barclays reveals two small cap ideas into ASCO conference » 05:55 05/31/23 05/31 05:55 05/31/23 05:55 RCUS Arcus Biosciences $20.26 / -1.71 (-7.78%) , KURA Kura Oncology $13.22 / -0.155 (-1.16%) Barclays reveled two… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 02:39:25 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events RCUS KURA RCUS Arcus Biosciences $20.26 / -1.71 (-7.78%) 05/26/23 Arcus Biosciences rises 25.4% 05/26/23 Arcus Biosciences rises 22.6% 05/26/23 Arcus Biosciences rises 20.6% 05/15/23 Arcus Biosciences jumps 2% amid expanded inflammation pact with Gilead KURA Kura Oncology $13.22 / -0.155 (-1.16%) 04/17/23 Kura reports preclinical data on use of farnesyl transferase inhibitors 02/09/23 Kura Oncology announces first patients dosed in Phase 2 trial of ziftomenib 01/24/23 Kura Oncology jumps 6% to $14.85 as FDA clears its IND application for KO-2806 01/24/23 Kura Oncology announces FDA clearance of IND application for KO-2806 RCUS KURA RCUS Arcus Biosciences $20.26 / -1.71 (-7.78%) 05/26/23 Citi Arcus Biosciences price target raised to $41 from $40 at Citi 03/09/23 Citi Arcus Biosciences price target lowered to $40 from $42 at Citi 12/21/22 Citi Arcus Biosciences selloff a buying opportunity, says Citi 12/21/22 Barclays Arcus Biosciences price target lowered to $36 from $60 at Barclays KURA Kura Oncology $13.22 / -0.155 (-1.16%) 05/16/23 BTIG Kura Oncology initiated with a Buy at BTIG 05/11/23 Stifel Kura Oncology price target lowered to $24 from $25 at Stifel 04/17/23 H.C. Wainwright Kura Oncology data support KO-2806 combination studies, says H.C. Wainwright 01/30/23 Stifel Kura Oncology initiated with a Buy at Stifel RCUS KURA RCUS Arcus Biosciences $20.26 / -1.71 (-7.78%) 05/09/23 Arcus Biosciences reports Q1 EPS ($1.09), consensus ($1.16) 02/28/23 Arcus Biosciences reports Q4 EPS (93c), consensus ($1.07) KURA Kura Oncology $13.22 / -0.155 (-1.16%) 02/23/23 Kura Oncology reports Q4 EPS (49c), consensus (57c) RCUS KURA RCUS Arcus Biosciences $20.26 / -1.71 (-7.78%) 12/20/22 What You Missed On Wall Street On Tuesday 12/20/22 What You Missed On Wall Street This Morning 12/19/22 Fly Intel: After-Hours Movers KURA Kura Oncology $13.22 / -0.155 (-1.16%) 05/17/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/21/23 Biotech Alert: Searches spiking for these stocks today 06/12/23 Biotech/Biopharma 06/02/23 2023 ASCO Annual Meeting 05/31/23 Kura Oncology, Inc. 06/15/23 Arcus Biosciences, Inc.

Tuesday
On The Fly	Fly Insider: Enviva, Diodes among week's notable insider trades » 15:31 05/30/23 05/30 15:31 05/30/23 15:31 ACAD Acadia Pharmaceuticals $23.73 / -1.055 (-4.26%) , SWX Southwest Gas $58.69 / +0.385 (+0.66%) , MODG Topgolf Callaway $17.28 / +0.155 (+0.91%) , EVA Enviva $8.88 / +0.33 (+3.86%) , ALGT Allegiant Travel $98.73 / -1.01 (-1.01%) , APTV Aptiv $90.97 / -1.17 (-1.27%) , BLNK Blink Charging $6.88 / -0.01 (-0.15%) , DIOD Diodes $92.29 / -3.63 (-3.78%) Welcome to "Fly Insider,"… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options SWX MODG EVA BLNK APTV ALGT ACAD SWX Southwest Gas $58.69 / +0.385 (+0.66%) 05/15/23 Icahn bought Illumina in Q1, sold shares of Herc and Newell 03/28/23 Carl Icahn increases stake in Southwest Gas by $18.5M 03/23/23 Carl Icahn increases stake in Southwest Gas by $31.6M 03/14/23 Carl Icahn increases stake in Southwest Gas by $32M MODG Topgolf Callaway $17.28 / +0.155 (+0.91%) 05/22/23 Topgolf Callaway exec buys $113.6K in common stock 05/09/23 Topgolf Callaway CEO says FY23 guidance cut reflects near-term volatility 05/09/23 Topgolf Callaway falls 8% to $19.90 after cutting FY23 EPS outlook 01/06/23 Callaway Golf, Stephen Curry enter multi-year partnership extension EVA Enviva $8.88 / +0.33 (+3.86%) 05/08/23 Enviva rises 18.6% 05/05/23 Enviva rises 27.9% 05/04/23 Enviva falls -62.9% 05/04/23 Enviva trading resumes BLNK Blink Charging $6.88 / -0.01 (-0.15%) 05/16/23 Blink Charging commissions first battery to store energized DC 05/15/23 Blink Charging names Ritsaart van Montfrans as Chairman of the Board 05/05/23 Blink Charging partners with Amerit Fleet Solutions for maintenance support 05/03/23 Blink Charging names Brendan Jones as CEO APTV Aptiv $90.97 / -1.17 (-1.27%) 05/15/23 Appaloosa takes stake in FedEx, exits Aptiv 02/14/23 Appaloosa takes stake in Disney, exits position in Mosaic 12/23/22 Aptiv completes acquisition of Wind River from TPG 12/15/22 Aptiv appoints Benjamin Lyon as CTO ALGT Allegiant Travel $98.73 / -1.01 (-1.01%) 05/04/23 Allegiant Travel reaches agreement on a two-year extension with IBT 05/03/23 Allegiant raises FY23 EPS view for airline only to $9.00-$13.00 from $5.00-$9.00 04/13/23 Allegiant Travel reports March 2023 total system passengers up 0.7% y-o-y 03/17/23 Allegiant Travel reports February scheduled service passengers up 13% ACAD Acadia Pharmaceuticals $23.73 / -1.055 (-4.26%) 03/12/23 Acadia Pharmaceuticals announces FDA approval of DAYBUE for Rett syndrome ACAD SWX MODG EVA ALGT APTV BLNK DIOD ACAD Acadia Pharmaceuticals $23.73 / -1.055 (-4.26%) 05/22/23 BofA Acadia Pharmaceuticals price target raised to $26 from $23 at BofA 05/09/23 JMP Securities Acadia Pharmaceuticals price target raised to $23 from $22 at JMP Securities 05/09/23 Citi Acadia Pharmaceuticals price target raised to $21.60 from $21 at Citi SWX Southwest Gas $58.69 / +0.385 (+0.66%) 02/07/23 JPMorgan Southwest Gas price target lowered to $75 from $78 at JPMorgan 12/14/22 Wells Fargo Southwest Gas price target raised to $73 from $66 at Wells Fargo 11/30/22 BofA Southwest Gas downgraded to Neutral at BofA as strategic review 'drags on' 11/30/22 BofA Southwest Gas downgraded to Neutral from Buy at BofA MODG Topgolf Callaway $17.28 / +0.155 (+0.91%) 05/24/23 TD Cowen Topgolf Callaway price target lowered to $18 from $20 at TD Cowen 05/18/23 Compass Point Topgolf Callaway price target lowered to $34 from $37 at Compass Point 04/18/23 KeyBanc Topgolf Callaway coverage transitioned with an Overweight at KeyBanc 04/10/23 Jefferies Market 'yet to fully appreciate' Topgolf Callaway transformation, says Jefferies EVA Enviva $8.88 / +0.33 (+3.86%) 05/04/23 Truist Enviva downgraded to Sell from Buy at Truist 04/06/23 RBC Capital Enviva price target lowered to $32 from $63 at RBC Capital 04/04/23 Truist Enviva price target lowered to $40 from $70 at Truist 04/04/23 Citi Enviva price target lowered to $32 from $62 at Citi ALGT Allegiant Travel $98.73 / -1.01 (-1.01%) 05/15/23 Raymond James Allegiant Travel price target raised to $123 from $118 at Raymond James 05/04/23 Susquehanna Allegiant Travel price target raised to $105 from $90 at Susquehanna 05/01/23 BofA Allegiant Travel downgraded to Underperform from Neutral at BofA 03/10/23 Barclays Allegiant Travel downgraded to Equal Weight from Overweight at Barclays APTV Aptiv $90.97 / -1.17 (-1.27%) 05/17/23 Guggenheim Aptiv price target lowered to $138 from $152 at Guggenheim 05/08/23 Barclays Aptiv price target lowered to $135 from $142 at Barclays 05/05/23 Deutsche Bank Aptiv price target lowered to $128 from $136 at Deutsche Bank 05/05/23 TD Cowen Aptiv price target lowered to $141 from $144 at TD Cowen BLNK Blink Charging $6.88 / -0.01 (-0.15%) 05/12/23 Barclays Blink Charging price target lowered to $10 from $11 at Barclays 05/11/23 DA Davidson Blink Charging price target lowered to $11 from $14 at DA Davidson 05/08/23 B. Riley Blink Charging price target lowered to $8 from $14 at B. Riley 04/25/23 Stifel Blink Charging price target lowered to $9 from $23 at Stifel DIOD Diodes $92.29 / -3.63 (-3.78%) 05/10/23 Wells Fargo Diodes price target lowered to $85 from $95 at Wells Fargo 02/08/23 Wells Fargo Diodes price target raised to $95 from $75 at Wells Fargo 02/07/23 Truist Diodes price target raised to $108 from $101 at Truist 02/07/23 TD Cowen Diodes price target raised to $110 from $95 at Cowen SWX MODG EVA DIOD BLNK APTV ALGT ACAD SWX Southwest Gas $58.69 / +0.385 (+0.66%) 05/09/23 Southwest Gas reports Q1 EPS $1.69, consensus $1.42 02/28/23 Southwest Gas reports Q4 adjusted EPS $1.16, consensus $1.58 MODG Topgolf Callaway $17.28 / +0.155 (+0.91%) 05/09/23 Topgolf Callaway sees Q2 revenue $1.17B-$1.195B, consensus $1.22B 05/09/23 Topgolf Callaway sees FY23 adjusted EPS 63c-69c, consensus 78c 05/09/23 Topgolf Callaway reports Q1 adjusted EPS 17c, consensus 16c 05/09/23 Topgolf Callaway reports Q1 EPS 13c, consensus 16c EVA Enviva $8.88 / +0.33 (+3.86%) 05/04/23 Enviva cuts 2023 adjusted EBITDA outlook to $200M-$250M from $305M-$355M 05/03/23 Enviva reports Q1 net loss ($116.8M) vs. ($45.3M) last year 03/01/23 Enviva sees FY23 adjusted EBITDA $305M-$335M 03/01/23 Enviva reports Q4 revenue $239.3M, consensus $422.3M DIOD Diodes $92.29 / -3.63 (-3.78%) 05/09/23 Diodes sees Q2 revenue $467M plus or minus 3%, consensus $480.55M 05/09/23 Diodes reports Q1 adjusted EPS $1.59, consensus $1.49 02/06/23 Diodes sees Q1 revenue $467M plus or minus 3%, consensus $466.93M 02/06/23 Diodes reports Q4 adjustedEPS $1.73, consensus $1.61 BLNK Blink Charging $6.88 / -0.01 (-0.15%) 05/09/23 Blink Charging sees FY23 revenue $100M-$110M, consensus $103.57M 05/09/23 Blink Charging reports Q1 EPS (53c), consensus (46c) 02/28/23 Blink Charging sees FY23 revenue $100M-$110M, consensus $91.57M 02/28/23 Blink Charging reports Q4 adjusted EPS (41c), consensus (48c) APTV Aptiv $90.97 / -1.17 (-1.27%) 05/04/23 Aptiv backs FY23 adjusted EPS view $4.00-$4.50, consensus $4.41 05/04/23 Aptiv reports Q1 adjusted EPS 91c, consensus 89c 02/02/23 Aptiv sees FY23 adjusted EPS $4.00-$4.50, consensus $4.73 02/02/23 Aptiv reports Q4 adjusted EPS $1.27, consensus $1.22 ALGT Allegiant Travel $98.73 / -1.01 (-1.01%) 05/16/23 Allegiant Travel reports April total system passengers down 0.1% y-o-y 05/03/23 Allegiant Travel reports Q1 EPS $3.04 ex items, consensus $2.30 02/01/23 Allegiant Travel sees FY23 airline EPS $9 02/01/23 Allegiant Travel reports Q4 adjusted EPS $3.17, consensus 69c ACAD Acadia Pharmaceuticals $23.73 / -1.055 (-4.26%) 05/08/23 Acadia Pharmaceuticals backs FY23 revenue view of $520M-$550M, consensus $556.5M 05/08/23 Acadia Pharmaceuticals reports Q1 EPS (27c), consensus (21c) 02/27/23 Acadia Pharmaceuticals sees FY23 revenue $520M-$550M, consensus $569.2M 02/27/23 Acadia Pharmaceuticals reports Q4 EPS (26c), consensus (24c) 08 Mar 07 Feb BLNK BLNK Blink Charging $6.88 / -0.01 (-0.15%) 02/10/23 DOT's coming EV charger rules may pressure Tesla to open network, Reuters says SWX MODG EVA BLNK APTV ALGT ACAD SWX Southwest Gas $58.69 / +0.385 (+0.66%) 03/23/23 Fly Intel: After-Hours Movers 03/20/23 Fly Insider: Southwest Gas, Pathward among week's notable insider trades 03/14/23 Fly Intel: After-Hours Movers MODG Topgolf Callaway $17.28 / +0.155 (+0.91%) 05/22/23 Fly Intel: After-Hours Movers 05/09/23 Fly Intel: After-Hours Movers 02/09/23 Fly Intel: After-Hours Movers EVA Enviva $8.88 / +0.33 (+3.86%) 05/05/23 Buy/Sell: Wall Street's top 10 stock calls this week 05/04/23 What You Missed On Wall Street On Thursday 05/04/23 What You Missed On Wall Street This Morning 01/20/23 Sell these stocks now, proven algorithm says BLNK Blink Charging $6.88 / -0.01 (-0.15%) 04/03/23 What You Missed This Week in EVs and Clean Energy 03/28/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/25/23 Short Report: Surprise GameStop profit spooks bears 03/06/23 What You Missed This Week in EVs and Clean Energy APTV Aptiv $90.97 / -1.17 (-1.27%) 02/22/23 Here's what Wall Street experts are saying about these EV names ahead of results 02/15/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations ALGT Allegiant Travel $98.73 / -1.01 (-1.01%) 05/01/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/06/23 Fly Insider Express, ServiceNow among week's notable insider trades 01/11/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations ACAD Acadia Pharmaceuticals $23.73 / -1.055 (-4.26%) 05/22/23 Biotech Alert: Searches spiking for these stocks today 05/31/23 51st Annual Technology, Media & Telecom Conference 05/31/23 Diodes 06/01/23 ACADIA Pharmaceuticals Inc 06/06/23 Topgolf Callaway Brands Corp 06/15/23 Enviva Inc. 06/21/23 Allegiant Travel Company MODG BLNK APTV ACAD MODG Topgolf Callaway $17.28 / +0.155 (+0.91%) 05/24/23 Topgolf Callaway Brands call volume above normal and directionally bullish 02/09/23 Topgolf Callaway Brands options imply 5.8% move in share price post-earnings 12/20/22 Unusually active option classes on open December 20th BLNK Blink Charging $6.88 / -0.01 (-0.15%) 05/23/23 Largest borrow rate increases among liquid names 05/22/23 Blink Charging call volume above normal and directionally bullish 05/15/23 Largest borrow rate increases among liquid names 05/09/23 Blink Charging call volume above normal and directionally bullish APTV Aptiv $90.97 / -1.17 (-1.27%) 02/14/23 Early notable gainers among liquid option names on February 14th 01/27/23 Early notable gainers among liquid option names on January 27th ACAD Acadia Pharmaceuticals $23.73 / -1.055 (-4.26%) 04/11/23 Largest borrow rate increases among liquid names
Options	Largest borrow rate increases among liquid names » 08:45 05/30/23 05/30 08:45 05/30/23 08:45 FRCB First Republic Bank / + , CIFR Cipher Mining $2.40 / +0.1 (+4.36%) , NKLA Nikola / + , RAIN Rain Oncology $1.10 / -0.04 (-3.51%) , RXDX Prometheus $198.53 / -0.07 (-0.04%) , MVST Microvast $1.37 / -0.045 (-3.19%) , ATOM Atomera $9.90 / +0.41 (+4.32%) , XBI SPDR S&P BIOTECH $84.26 / +0.75 (+0.90%) , JWN Nordstrom $16.03 / +0.82 (+5.39%) , RUM Rumble $9.56 / -0.36 (-3.63%) Latest data shows the… Latest data shows the largest indicative borrow rate increases among liquid option names include: First Republic Bank (FRCB) 42.75% +17.11, Cipher Mining (CIFR) 45.84% +11.33, Nikola (NKLA) 83.45% +5.61, Rain Therapeutics (RAIN) 15.69% +3.43, Prometheus Biosciences (RXDX) 3.67% +3.41, Microvast Holdings (MVST) 5.17% +2.44, Atomera (ATOM) 11.22% +2.23, SPDR S&P Biotech (XBI) 6.07% +2.07, Nordstrom (JWN) 4.68% +1.98, and Rumble (RUM) 37.69% +1.94. ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options RXDX RUM RAIN NKLA MVST JWN FRCB CIFR ATOM RXDX Prometheus $198.53 / -0.07 (-0.04%) 05/16/23 Prometheus, Seagen slip after FTC sues to block Horizon acquisition 04/16/23 Fly Intel: Top five weekend stock stories 04/16/23 Merck acquires Prometheus Biosciences for $200 per share 12/07/22 Prometheus announces results for PRA023 in APOLLO-CD Phase 2 study RUM Rumble $9.56 / -0.36 (-3.63%) 05/18/23 Rumble launches alpha release of Creator Sponsorship Marketplace 05/16/23 Culper Research calls Rumble 'unraveling stock promotion', remains short 04/27/23 Rumble down 4% to $7.81 after Culper Research short report 04/12/23 Rumble partners with RNC to stream first GOP debate of 2024 primaries RAIN Rain Oncology $1.10 / -0.04 (-3.51%) 05/30/23 Rain Oncology cofounder Robert Doebele to assume role of CMO 05/30/23 Rain Oncology provides update, outlines priorities for milademetan program 05/22/23 Rain Oncology Phase 3 MANTRA trial did not meet primary endpoint 01/23/23 Rain Oncology announces publication of Phase 1 data of milademetan NKLA Nikola / + 05/25/23 Nikola under pressure after receiving delisting notice 05/24/23 Nikola encourages stockholders to vote for Proposal 2 05/09/23 Nikola shares plunge 15% after quarterly report, exit from European JV 05/09/23 Nikola: Coolidge Phase 2 assembly hall expansion on track for end of Q2 MVST Microvast $1.37 / -0.045 (-3.19%) 04/13/23 Microvast announces appointment of Isida Tushe as general counsel 03/15/23 Microvast selected by MAFI & TREPEL as battery supplier for EV tractors 12/07/22 Microvast secures contract to supply BESS to U.S. customer JWN Nordstrom $16.03 / +0.82 (+5.39%) 05/10/23 Nordstrom names Cathy Smith as CFO, effective May 29 04/17/23 Nordstrom appoints Eric Sprunk to Board of Directors 04/17/23 Tilly's names Laura Janney as EVP, Chief Merchandising Officer 04/14/23 Nordstrom appoints Jason Morris as Chief Technology and Information Officer FRCB First Republic Bank / + 05/25/23 CRE exposure may pressure ratings of regional banks, Fitch Ratings says CIFR Cipher Mining $2.40 / +0.1 (+4.36%) 05/01/23 Cipher Mining mines 406 bitcoin in April 03/20/23 Cipher names Patrick Kelly and Will Iwaschuk co- presidents, Stennett as CAO 01/10/23 Cipher Mining ends 2022 with 394 Bitcoin 12/20/22 Cipher Mining acquires additional new mining rigs for Odessa data center ATOM Atomera $9.90 / +0.41 (+4.32%) 04/26/23 Atomera jumps 40% to $7.32 after entering pact with STMicroelectronics 04/26/23 Atomera signs commercial license agreement with STMicroelectronics 03/12/23 Atomera says not materially impacted by Silicon Valley Bank closure 01/12/23 Atomera collaborates with Arizona State over semiconductor material advancement FRCB CIFR NKLA RAIN RXDX MVST ATOM XBI JWN RUM FRCB First Republic Bank / + CIFR Cipher Mining $2.40 / +0.1 (+4.36%) 04/25/23 Canaccord Cipher Mining initiated with a Buy at Canaccord 03/14/23 Cantor Fitzgerald Cipher Mining initiated with an Overweight at Cantor Fitzgerald 03/13/23 Cantor Fitzgerald Cipher Mining initiated with an Overweight at Cantor Fitzgerald 02/21/23 Needham Cipher Mining initiated with a Buy at Needham NKLA Nikola / + 05/10/23 TD Cowen TD Cowen downgrades Nikola to Market Perform on persistent liquidity overhang 05/09/23 TD Cowen Nikola downgraded to Market Perform from Outperform at TD Cowen 03/31/23 BTIG BTIG downgrades Nikola to Neutral after stock offering, expects further dilution 03/31/23 BTIG Nikola downgraded to Neutral from Buy at BTIG RAIN Rain Oncology $1.10 / -0.04 (-3.51%) 05/23/23 H.C. Wainwright Rain Oncology downgraded to Neutral from Buy at H.C. Wainwright 05/23/23 Oppenheimer Rain Oncology downgraded to Perform on Phase 3 failure at Oppenheimer 05/23/23 Citi Rain Oncology downgraded to Neutral from Buy at Citi 05/22/23 Oppenheimer Rain Oncology downgraded to Perform from Outperform at Oppenheimer RXDX Prometheus $198.53 / -0.07 (-0.04%) 05/10/23 Jefferies Prometheus downgraded to Hold from Buy at Jefferies 04/18/23 Wells Fargo Prometheus downgraded to Equal Weight from Overweight at Wells Fargo 04/18/23 RBC Capital Prometheus downgraded to Sector Perform from Outperform at RBC Capital 04/17/23 Credit Suisse Prometheus downgraded to Neutral from Outperform at Credit Suisse MVST Microvast $1.37 / -0.045 (-3.19%) 04/03/23 H.C. Wainwright Microvast initiated with a Buy at H.C. Wainwright 08/18/22 Oppenheimer Oppenheimer starts Microvast with Outperform, $8 price target 08/18/22 Oppenheimer Microvast initiated with an Outperform at Oppenheimer ATOM Atomera $9.90 / +0.41 (+4.32%) 04/27/23 Craig-Hallum Atomera price target raised to $17 from $13 at Craig-Hallum 11/10/22 Craig-Hallum Atomera price target lowered to $13 from $22 at Craig-Hallum XBI SPDR S&P BIOTECH $84.26 / +0.75 (+0.90%) JWN Nordstrom $16.03 / +0.82 (+5.39%) 05/25/23 Citi Nordstrom price target lowered to $17 from $20 at Citi 05/02/23 Barclays Nordstrom price target lowered to $14 from $16 at Barclays 03/08/23 Argus Nordstrom upgraded to Buy from Hold at Argus 03/03/23 Morgan Stanley Nordstrom assumed with an Underweight at Morgan Stanley RUM Rumble $9.56 / -0.36 (-3.63%) 05/16/23 DA Davidson Rumble price target lowered to $12 from $15 at DA Davidson 12/02/22 Oppenheimer Rumble initiated with a Perform at Oppenheimer RXDX RUM RAIN NKLA MVST JWN CIFR RXDX Prometheus $198.53 / -0.07 (-0.04%) 05/09/23 Prometheus reports Q1 EPS (86c), consensus (91c) 02/28/23 Prometheus reports Q4 EPS (90c), consensus (92c) RUM Rumble $9.56 / -0.36 (-3.63%) 05/16/23 Rumble reports Q1 EPS (14c) vs. (2c) last year 03/30/23 Rumble reports Q4 EPS 0c, two estimates (2c) RAIN Rain Oncology $1.10 / -0.04 (-3.51%) 05/11/23 Rain Oncology reports Q1 EPS (56c), consensus (61c) 03/09/23 Rain Oncology reports Q4 EPS (70c), consensus (56c) NKLA Nikola / + 05/09/23 Nikola reports Q1 adjusted EPS (26c), consensus (26c) 05/08/23 Notable companies reporting before tomorrow's open 02/23/23 Nikola reports Q4 adjusted EPS (37c), consensus (43c) MVST Microvast $1.37 / -0.045 (-3.19%) 05/09/23 Microvast sees Q2 revenue $63M-$67M 05/09/23 Microvast raises FY23 revenue view to $348M-$368M JWN Nordstrom $16.03 / +0.82 (+5.39%) 03/02/23 Nordstrom reports Q4 EPS 74c, consensus 66c 03/02/23 Nordstrom sees FY23 adjusted EPS $1.80-$2.20, consensus $1.93 03/02/23 Notable companies reporting after market close 01/19/23 Nordstrom cuts FY22 adjusted EPS view to $1.50-$1.70 from $2.30-$2.60 CIFR Cipher Mining $2.40 / +0.1 (+4.36%) 05/09/23 Cipher Mining reports Q1 adjusted EPS 3c, consensus (2c) 03/14/23 Cipher Mining reports FY22 adjusted EPS (26c) vs (4c) last year 31 Mar 09 Dec RUM NKLA MVST JWN FRCB RUM Rumble $9.56 / -0.36 (-3.63%) 04/27/23 Culper short Rumble, says unique user base 'fraction' of claimed size 04/27/23 Culper Research announces short position in Rumble 01/05/23 Bear Cave sees 'more problems' at Rumble NKLA Nikola / + 01/20/23 Nikola speculated by The Deal as 'attractive' to activist 12/01/22 Fuzzy Panda short Fisker, says 'asset-light' model really 'liability-heavy' MVST Microvast $1.37 / -0.045 (-3.19%) 05/23/23 U.S. DOE ends plans for $200M grant for Microvast, Reuters reports 02/16/23 DOE reviewing $200M grant to Microvast amid concerns, Bloomberg says JWN Nordstrom $16.03 / +0.82 (+5.39%) 04/19/23 Ryan Cohen pulls Nordstrom board candidates, Bloomberg reports 02/06/23 Nordstrom tells Fox open to Cohen views, hasn't sought talks in 'years' 02/02/23 Ryan Cohen amasses sizable stake in Nordstrom, WSJ reports FRCB First Republic Bank / + 05/25/23 JPMorgan informs some First Republic staff of layoffs, Reuters says 05/24/23 DOJ probing trading by First Republic employees amid collapse, Bloomberg says 05/24/23 DOJ probing trading by First Republic employees amid collapse, Bloomberg says 05/05/23 SEC probing trades by First Republic executives, Bloomberg reports RXDX RUM RAIN NKLA MVST JWN FRCB CIFR ATOM RXDX Prometheus $198.53 / -0.07 (-0.04%) 05/16/23 What You Missed On Wall Street On Tuesday 04/19/23 Biotech Alert: Searches spiking for these stocks today 04/17/23 What You Missed On Wall Street This Morning 04/17/23 Fly Intel: Pre-market Movers RUM Rumble $9.56 / -0.36 (-3.63%) 03/31/23 Fly Intel: Pre-market Movers 03/30/23 Fly Intel: After-Hours Movers 01/05/23 What You Missed On Wall Street This Morning 12/02/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations RAIN Rain Oncology $1.10 / -0.04 (-3.51%) 05/23/23 What You Missed On Wall Street On Tuesday 05/23/23 What You Missed On Wall Street This Morning 05/23/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/22/23 What You Missed On Wall Street On Monday NKLA Nikola / + 05/15/23 What You Missed This Week in EVs and Clean Energy 05/10/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/09/23 What You Missed On Wall Street On Tuesday 05/09/23 Fly Intel: Pre-market Movers MVST Microvast $1.37 / -0.045 (-3.19%) 05/10/23 What You Missed On Wall Street On Wednesday 05/10/23 What You Missed On Wall Street This Morning 01/30/23 Here's what Wall St. experts are saying about these automakers ahead of earnings JWN Nordstrom $16.03 / +0.82 (+5.39%) 05/07/23 Short Report: Bears increase exposure to Lemonade after earnings-driven spike 04/02/23 Short Report: Bearish views on Lovesac remain elevated despite earnings beat 03/11/23 Buy/Sell: Wall Street's top 10 stock calls this week 03/08/23 What You Missed On Wall Street On Wednesday FRCB First Republic Bank / + 05/26/23 What You Missed On Wall Street On Friday 05/26/23 What You Missed On Wall Street This Morning 05/25/23 What You Missed On Wall Street On Thursday CIFR Cipher Mining $2.40 / +0.1 (+4.36%) 02/07/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations ATOM Atomera $9.90 / +0.41 (+4.32%) 04/26/23 Fly Intel: After-Hours Movers 06/02/23 2023 ASCO Annual Meeting 05/31/23 Nordstrom - JWN 05/31/23 Rain Oncology Inc. 06/06/23 Nordstrom Inc. 06/07/23 Nikola Corporation 06/15/23 Prometheus Biosciences, Inc. 06/16/23 Rumble Inc 07/10/23 Prometheus 07/11/23 Prometheus XBI RXDX RUM NKLA MVST JWN CIFR ATOM XBI SPDR S&P BIOTECH $84.26 / +0.75 (+0.90%) 04/21/23 Largest borrow rate increases among liquid names 01/27/23 Largest borrow rate increases among liquid names RXDX Prometheus $198.53 / -0.07 (-0.04%) 12/05/22 Prometheus Biosciences put volume heavy and directionally bearish RUM Rumble $9.56 / -0.36 (-3.63%) 05/26/23 Rumble put volume heavy and directionally bearish 05/24/23 Largest borrow rate increases among liquid names 05/15/23 Rumble options imply 10.0% move in share price post-earnings 05/10/23 Rumble call volume above normal and directionally bullish NKLA Nikola / + 05/22/23 Largest borrow rate increases among liquid names 05/19/23 Unusually active option classes on open May 19th 05/17/23 Largest borrow rate increases among liquid names 05/11/23 Largest borrow rate increases among liquid names MVST Microvast $1.37 / -0.045 (-3.19%) 05/16/23 Largest borrow rate increases among liquid names JWN Nordstrom $16.03 / +0.82 (+5.39%) 05/26/23 Largest borrow rate increases among liquid names 04/25/23 Nordstrom call volume above normal and directionally bullish 04/10/23 Nordstrom call volume above normal and directionally bullish 03/16/23 Nordstrom call volume above normal and directionally bullish CIFR Cipher Mining $2.40 / +0.1 (+4.36%) 05/19/23 Largest borrow rate increases among liquid names 05/18/23 Largest borrow rate increases among liquid names 02/17/23 Largest borrow rate increases among liquid names ATOM Atomera $9.90 / +0.41 (+4.32%) 05/15/23 Largest borrow rate increases among liquid names

Over a week ago
On The Fly	Biotech Alert: Searches spiking for these stocks today » 10:54 05/25/23 05/25 10:54 05/25/23 10:54 KRYS Krystal Biotech $117.51 / -1.31 (-1.10%) , BPMC Blueprint Medicines $55.95 / -2.01 (-3.47%) , RNA Avidity Biosciences $10.98 / -0.315 (-2.79%) , ACHV Achieve Life Sciences $6.03 / +0.02 (+0.33%) , OTLK Outlook Therapeutics $1.46 / -0.04 (-2.68%) These names in the… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events RNA OTLK KRYS BPMC ACHV RNA Avidity Biosciences $10.98 / -0.315 (-2.79%) 05/17/23 Avidity Biosciences: FDA eases partial clinical hold on AOC 1001 04/27/23 Avidity Biosciences announces data from MARINA clinical trial of AOC 1001 04/24/23 Avidity Biosciences granted FDA Fast Track designation to AOC 1044 03/30/23 Avidity Biosciences provides regulatory update on dystrophy candidate AOC 1001 OTLK Outlook Therapeutics $1.46 / -0.04 (-2.68%) 03/13/23 Outlook Therapeutics confirms no exposure to Silivon Valley Bank 02/14/23 Outlook Therapeutics announces anticipated milestones 02/14/23 Outlook sees cash runway through anticipated FDA approval of ONS-5010 01/19/23 Outlook Therapeutics appoints Surendra Sharma as SVP, medical affairs KRYS Krystal Biotech $117.51 / -1.31 (-1.10%) 05/23/23 Krystal Biotech director Janney sells 50,000 common shares 05/23/23 Option Care Health selected by Krystal Biotech as part of Vyjuvek distribution 05/22/23 Krystal Biotech sees cash runway through end of 2026 05/19/23 Krystal Biotech up 5% after receiving FDA approval for Vyjuvek BPMC Blueprint Medicines $55.95 / -2.01 (-3.47%) 05/23/23 Blueprint Medicines announces publication of results from PIONEER Trial 05/22/23 Blueprint Medicines announces FDA approval of AYVAKIT from treatment of SM 05/22/23 Blueprint Medicines' Ayvakit gets expanded approval for ISM 04/26/23 Blueprint Medicines to present new clinical data at 2023 ASCO meeting ACHV Achieve Life Sciences $6.03 / +0.02 (+0.33%) 05/23/23 Achieve Life Sciences' cytisinicline shows smoking cessation benefit in trial 05/17/23 Achieve Life Sciences refinances loan with Silicon Valley Bank 04/20/23 Achieve Life Sciences announces Phase 2 ORCA-V1 trial results 03/30/23 Achieve Life Sciences announces board refresh KRYS BPMC RNA ACHV OTLK KRYS Krystal Biotech $117.51 / -1.31 (-1.10%) 05/25/23 BofA Krystal Biotech price target raised to $140 from $118 at BofA 05/24/23 Alliance Global Partners Abeona 'well positioned' for potential EB-101 approval, says Alliance Global 05/24/23 Stifel Krystal Biotech price target raised to $145 from $102 at Stifel 05/22/23 Guggenheim Krystal Biotech price target raised to $130 from $101 at Guggenheim BPMC Blueprint Medicines $55.95 / -2.01 (-3.47%) 05/23/23 Guggenheim Blueprint Medicines price target raised to $82 from $78 at Guggenheim 05/23/23 H.C. Wainwright Blueprint Medicines price target raised to $85 from $75 at H.C. Wainwright 05/23/23 Barclays Blueprint Medicines price target raised to $46 from $44 at Barclays 05/05/23 H.C. Wainwright Blueprint Medicines price target raised to $75 from $70 at H.C. Wainwright RNA Avidity Biosciences $10.98 / -0.315 (-2.79%) 05/22/23 Evercore ISI Avidity Biosciences upgraded to Outperform from In Line at Evercore ISI 05/11/23 Wells Fargo Avidity Biosciences price target lowered to $50 from $55 at Wells Fargo 03/31/23 Evercore ISI Avidity Biosciences downgraded to In Line at Evercore on safety concerns 03/31/23 Evercore ISI Avidity Biosciences downgraded to In Line from Outperform at Evercore ISI ACHV Achieve Life Sciences $6.03 / +0.02 (+0.33%) 11/16/22 Maxim Achieve Life Sciences price target lowered to $8 from $21 at Maxim 11/15/22 Oppenheimer Achieve Life Sciences price target lowered to $20 from $27 at Oppenheimer OTLK Outlook Therapeutics $1.46 / -0.04 (-2.68%) 04/03/23 Guggenheim Guggenheim starts Outlook Therapeutics at Buy on Lytenava opportunity 04/03/23 Guggenheim Outlook Therapeutics initiated with a Buy at Guggenheim 02/06/23 Cantor Fitzgerald Outlook Therapeutics initiated with an Overweight at Cantor Fitzgerald 10/31/22 BTIG Outlook Therapeutics initiated with a Buy at BTIG RNA OTLK KRYS BPMC ACHV RNA Avidity Biosciences $10.98 / -0.315 (-2.79%) 05/09/23 Avidity Biosciences reports Q1 EPS (74c), consensus (85c) 02/28/23 Avidity Biosciences reports Q4 EPS (88c), consensus (89c) OTLK Outlook Therapeutics $1.46 / -0.04 (-2.68%) 05/15/23 Outlook Therapeutics reports Q2 EPS (3c), consensus (6c) 02/14/23 Outlook Therapeutics reports Q1 EPS (8c), consensus (5c) 12/29/22 Outlook Therapeutics reports 2022 EPS (31c), consensus (31c) KRYS Krystal Biotech $117.51 / -1.31 (-1.10%) 05/08/23 Krystal Biotech reports Q1 EPS ($1.76), consensus ($1.44) 02/27/23 Krystal Biotech reports Q4 EPS ($1.25), consensus ($1.32) BPMC Blueprint Medicines $55.95 / -2.01 (-3.47%) 05/04/23 Blueprint Medicines reports Q1 EPS ($2.15), consensus ($2.67) 02/16/23 Blueprint Medicines reports Q4 EPS ($2.65), consensus ($2.65) ACHV Achieve Life Sciences $6.03 / +0.02 (+0.33%) 05/09/23 Achieve Life Sciences reports Q1 EPS (50c), consensus (69c) 03/16/23 Achieve Life Sciences reports Q4 EPS (83c), consensus (83c) 16 Dec RNA RNA Avidity Biosciences $10.98 / -0.315 (-2.79%) 04/11/23 Drugmakers call for abortion pill ruling reversal, Reuters reports RNA KRYS BPMC ACHV RNA Avidity Biosciences $10.98 / -0.315 (-2.79%) 04/28/23 What You Missed On Wall Street On Friday 04/28/23 What You Missed On Wall Street This Morning 03/31/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/30/23 What You Missed On Wall Street On Thursday KRYS Krystal Biotech $117.51 / -1.31 (-1.10%) 05/24/23 Biotech Alert: Searches spiking for these stocks today 05/22/23 Biotech Alert: Searches spiking for these stocks today 04/06/23 Fly Intel: After-Hours Movers 02/28/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations BPMC Blueprint Medicines $55.95 / -2.01 (-3.47%) 05/22/23 Fly Intel: After-Hours Movers 03/28/23 Fly Intel: After-Hours Movers ACHV Achieve Life Sciences $6.03 / +0.02 (+0.33%) 01/12/23 Biotech Alert: Searches spiking for these stocks today 08/02/23 Biotech/Biopharma 06/02/23 2023 ASCO Annual Meeting 07/11/23 Outlook Therapeutics - OTLK 08/29/23 PDUFA Date for ONS-5010/Lytenava 06/07/23 Achieve Life Sciences, Inc. 06/15/23 Avidity Biosciences, Inc. 06/21/23 Blueprint Medicines Corp.

Get Full Fly Access

Breaking market intelligence sent straight to you: Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.

Up-to-date information on important industry events: Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.

News focused on the companies in your portfolio: Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.

14 Day Free Trial